Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Obesity Treatment Companies

Companies involved in obesity treatment contribute to the development, manufacturing, and distribution of therapies, medications, medical devices, and technologies aimed at addressing obesity. These companies operate in various segments, including pharmaceuticals, medical devices, healthcare services, and more.

Obesity Treatment Key Companies

Latest Obesity Treatment Companies Update

August 2023: Novo Nordisk launches Wegovy (semaglutide), a new GLP-1 agonist medication showing substantial weight loss in clinical trials.

July 2023: Eli Lilly receives FDA approval for Mounjaro (tirzepatide), another GLP-1 agonist expected to offer similar weight-loss benefits.

December 2022: Vivus Therapeutics announces the commercial launch of Qsymia (phentermine/topiramate), a prescription weight-loss medication approved for long-term use.

September 2023: A Phase 3 trial begins for Rhythm Therapeutics' setmelanotide, a potential drug targeting appetite regulation in the hypothalamus.

August 2023: A study published in The New England Journal of Medicine suggests that intermittent fasting could be an effective weight-loss strategy.

July 2023: Researchers at the University of California, San Diego develop a new blood test that may predict individual responses to different weight-loss interventions.

List of Obesity Treatment Key Companies in the Market

VIVUS, Inc. (U.S.)

Arena Pharmaceuticals, Inc. (U.S.)

Hoffmann-La Roche, Ltd. (Switzerland)

Novo Nordisk A/S (Denmark)

Orexigen Therapeutics, Inc. (U.S.)

Allergan (Republic of Ireland)

Cousin Biotech (France)

EnteroMedics, Inc. (U.S.)

Johnson & Johnson Services, Inc. (U.S.)

Medtronic (U.S.)

USGI Medical, Inc. (U.S.)

Mediflex Surgical Products (U.S.)

Covidien plc (Republic of Ireland)

Olympus Corporation (Japan)

Takeda Pharmaceuticals Company Limited

Eisai Co. Ltd.

Novo Nordisk A/S

Zafgen

Rhythm Pharmaceuticals

Zydus Cadila

Norgine B.V.

Vivus Therapeutics

Arena Pharmaceuticals Inc.

Orexigen Therapeutics Inc

Obesity Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.